Figure 7
Barasertib-HQPA plus nab-paclitaxel in melanoma cell panel. MBA72 and HBL cells were incubated with 3, 30, 300 nM and 3 μM barasertib-HQPA (bar) plus 50nM nab-paclitaxel (n-pac) given in three schedules, simultaneous (3 days) and 3 days-barasertib-HQPA before or after 3 days-nab-paclitaxel. A. The survival of cells is reported as dose/effect plots. B. The quantification of the CIs of each drugs combination by CompuSyn software is summarized in the table.